About
Susan Greenfield is a British neuroscientist, writer, broadcaster, and founder/CEO of Neuro-Bio Ltd, an Oxfordshire biotechnology company developing diagnostics and therapeutics for Alzheimer's disease. Her official site highlights a long research career rooted in Oxford alongside extensive public science communication. WIPO's UK IP-finance case study profiles her as the scientific founder leading Neuro-Bio's patented neurodegeneration program and fundraising efforts.
Areas of interest
neurosciencealzheimer's diseaseparkinson's diseaseneurodegenerationbiotechconsciousnessscience communicationscreen technologieswomen in sciencepublic policy